Richmond, Jan. 15, 2024 (GLOBE NEWSWIRE) -- According to a research report "Metabolomics Market”, by Product & Services (Metabolomics Instruments, Separation Tools Detection Tools), Application (Biomarker discovery, Drug discovery, Toxicology testing, Nutrigenomics, Functional Genomics, Personalized medicine, Other Applications), Indication (Cancer, Cardiovascular Disorders, Neurological Disorders, Metabolic Disorders, Inborn Errors of Metabolism, Other Indications), End User (Academic and Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Other End Users), and Region - Global Forecast to 2030.
Global Metabolomics Market Report Scope:
| Report | Details |
| Market size value in 2023 | USD 2.20 Billion |
| Market size value in 2030 | USD 5.0 Billion |
| CAGR (2023-2030) | 12.5% |
| Forecast Period | 2023–2030 |
| Historic Data | 2019 |
| Forecast Units | Value (USD Million/USD Billion) |
| Segments Covered | Indication, Product & Services, End User and Region |
| Geographies Covered | North America, Europe, Asia Pacific, and RoW |
| |
| |
| Sample of Companies Covered |
|
| |
|
Download the Sample - https://www.marketdigits.com/request/sample/1855
TOC Covers in Depth & Breath on Metabolomics Market
170 - Market Data Tables
65 - List of Figures
225 – Pages
The report includes Vendor Assessment (Company Profiles, Market Positioning, Strategies, Recent Developments, Capabilities & Product Offerings / Mapping), Technology Assessment (Developments & Economic Impact), Partner & Customer Ecosystem (Product Services, Proposition & Key Features) Competitive Index & Regional FootPrint by MarketDigits.
Market Overview
The metabolomics market is witnessing substantial growth driven by increasing applications in personalized medicine, biomarker discovery, and drug development. Metabolomics involves the comprehensive study of small molecules, known as metabolites, within biological systems. It plays a crucial role in understanding cellular processes, disease mechanisms, and identifying potential diagnostic markers. The rising prevalence of chronic diseases, advancements in analytical technologies like mass spectrometry and nuclear magnetic resonance spectroscopy, and the expanding field of precision medicine contribute to the market's expansion. Metabolomics aids in unraveling complex biological interactions, enabling targeted therapeutic interventions. Additionally, collaborations between academic research institutions and pharmaceutical companies further propel market advancements. As the demand for personalized healthcare solutions continues to surge, the metabolomics market is poised for continuous growth, fostering innovation and transformative insights into human health and disease.
Major Vendors in the Global Metabolomics Market:
- Afekta Technologies Ltd.
- Agilent Technologies, Inc.
- Analytik Jena GmbH
- BASF SE
- BGI
- Biocrates life sciences AG
- Bruker
- Creative Proteomics
- DNA Xperts Private Limited
- Human Metabolome Technologies Inc.
- LECO Corporation
- Metabolomic Technologies Inc.
- Metabolon, Inc.
- metaSysX
- Metware Biotechnology Co.,Ltd.
- MS-OMICS
- PerkinElmer Inc.
- SCIEX (Danaher)
- Shimadzu Corporation
- Thermo Fisher Scientific Inc.
- Vproteomics
- Waters Corporation
Request for Discount @ https://www.marketdigits.com/request/discount/1855
Increasing Prevalence Of Diseases In Recent Years
The escalating prevalence of diseases in recent years stands as a significant driver propelling the growth of the metabolomics market. As chronic conditions like cardiovascular diseases, diabetes, and cancer become increasingly prevalent worldwide, there is a growing need for advanced diagnostic tools and personalized treatment strategies. Metabolomics, with its ability to provide comprehensive insights into the metabolic processes and biochemical changes associated with various diseases, has emerged as a crucial component in the field of medical research. The rising demand for precision medicine and targeted therapeutic approaches has further accentuated the importance of metabolomics in understanding disease mechanisms, identifying biomarkers, and facilitating drug development. The application of advanced analytical techniques in metabolomics, such as mass spectrometry and nuclear magnetic resonance spectroscopy, enhances the accuracy and efficiency of disease diagnosis and prognosis, positioning metabolomics as a key player in addressing the global health challenges posed by the increasing burden of diseases.
Market Dynamics
Drivers:
- Increasing Prevalence Of Diseases In Recent Years
- Increasing Number Of Government Activities To Promote Use Of Metabolomics
Opportunities:
- Rising Interest in Personalized Medicine
- Rapid Technological Advancements
Growing Investment in Metabolomics Research
The escalating investment in metabolomics research represents a substantial opportunity for the global metabolomics market. With a surge in funding from both public and private sectors, the market is poised for significant advancements. This financial support enables extensive research and development activities focused on enhancing analytical techniques, expanding applications, and discovering novel biomarkers. The influx of funds also supports collaborations between academic institutions, pharmaceutical companies, and technology developers, fostering innovation in metabolomics. Moreover, the growing recognition of metabolomics as a vital tool in deciphering complex biological processes and disease mechanisms fuels increased investment. As research initiatives gain momentum, the market benefits from the exploration of new therapeutic avenues, diagnostic approaches, and the potential for personalized medicine. The convergence of financial backing and scientific curiosity creates a robust foundation for the metabolomics market to flourish, driving transformative breakthroughs in understanding and managing various health conditions.
The market for Metabolomics is dominated by North America.
North America stands as the dominating region in the Metabolomics Market, with the United States and Canada playing pivotal roles in driving this market dominance. The region's leadership is attributed to robust research and development activities, substantial investments in healthcare, and a well-established healthcare infrastructure. In the United States alone, the National Institutes of Health (NIH) has been a key contributor, investing significantly in metabolomics research. Canada, with its strong focus on scientific research and healthcare excellence, also contributes significantly to the North American leadership in the metabolomics sector. The collaborative efforts between academic institutions, research organizations, and the pharmaceutical industry in both countries further amplify the region's influence. The continual growth in funding and research initiatives underscores North America's central role in advancing metabolomics technologies and applications on the global stage.
The Separation tools Segment is Anticipated to Hold the Largest Market Share During the Forecast Period
Based on Product & Services the Metabolomics market is segmented into Metabolomics Instruments, Separation Tools Detection Tools. Separation tools have emerged as the dominating segment in the Metabolomics Market, capturing the largest share within the industry. These tools play a pivotal role in metabolomics analysis by facilitating the isolation and identification of individual metabolites from complex biological samples. Techniques such as chromatography and mass spectrometry, integral components of separation tools, enable the precise separation and characterization of metabolites, contributing to the comprehensive understanding of metabolic pathways. The high demand for accurate and sensitive analytical methods in metabolomics research and diagnostics has propelled the prominence of separation tools. Their capability to enhance the resolution and sensitivity of metabolite detection positions them as indispensable in the metabolomics workflow. As the metabolomics market continues to expand, driven by advancements in analytical technologies, the dominance of separation tools is expected to persist, shaping the landscape of metabolomics studies and applications.
Inquire Before Buying: https://www.marketdigits.com/request/enquiry-before-buying/1855
Browse Similar Reports:
Cardiac Biomarker Diagnostic Test Kits Market 2030 By Type, Distribution Channel, End-user and Region - Partner & Customer Ecosystem (Product Services, Proposition & Key Features) Competitive Index & Regional Footprints by MarketDigits
Asthma and COPD Biomarkers Market 2030 By Type, Distribution Channel, End-user and Region - Partner & Customer Ecosystem (Product Services, Proposition & Key Features) Competitive Index & Regional Footprints by MarketDigits
Cancer Biomarker Market 2030 By Type, Distribution Channel, End-user and Region - Partner & Customer Ecosystem (Product Services, Proposition & Key Features) Competitive Index & Regional Footprints by MarketDigits
About MarketDigits:
MarketDigits is one of the leading business research and consulting companies that helps clients to tap new and emerging opportunities and revenue areas, thereby assisting them in operational and strategic decision-making. We at MarketDigits believe that a market is a small place and an interface between the supplier and the consumer, thus our focus remains mainly on business research that includes the entire value chain and not only the markets.
We offer services that are most relevant and beneficial to the users, which help businesses to sustain themselves in this competitive market. Our detailed and in-depth analysis of the markets catering to strategic, tactical, and operational data analysis & reporting needs of various industries utilize advanced technology so that our clients get better insights into the markets and identify lucrative opportunities and areas of incremental revenues.
Contact Us:
MarketDigits
1248 CarMia Way Richmond,
VA 23235,
United States.
USA: +1 847 450 0808
Email: sales@marketdigits.com
Web: https://www.marketdigits.com
Follow Us on: | Twitter | LinkedIn |
